Canadian Sec - Delayed Quote CAD

METheraHld (METX.CN)

Compare
8.00
0.00
(0.00%)
At close: January 30 at 3:35:05 PM EST
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for METX.CN

Recent News: METX.CN

View More
ME Therapeutics Announces That Its First Therapeutic mRNA Candidate Shows Encouraging Anti-Cancer Efficacy in Vivo

ME Therapeutics Announces That Its First Therapeutic mRNA Candidate Shows Encouraging Anti-Cancer Efficacy in Vivo
Newsfile 17 days ago
ME Therapeutics Holdings Inc. Appoints Chief Business Officer

ME Therapeutics Holdings Inc. Appoints Chief Business Officer
Newsfile 3 months ago
ME Therapeutics Holdings Inc. Provides Research and Development Update and Corporate Update

ME Therapeutics Holdings Inc. Provides Research and Development Update and Corporate Update
Newsfile 3 months ago
ME Therapeutics Announces the Start of Testing of First mRNA Formulations from NanoVation Therapeutics Collaboration

ME Therapeutics Announces the Start of Testing of First mRNA Formulations from NanoVation Therapeutics Collaboration
Newsfile 4 months ago
ME Therapeutics Announces New Collaboration with NanoVation Therapeutics on Advanced Therapeutic mRNA Delivery to Myeloid Cells

ME Therapeutics Announces New Collaboration with NanoVation Therapeutics on Advanced Therapeutic mRNA Delivery to Myeloid Cells
Newsfile 6 months ago
ME Therapeutics Holdings Inc. Announces the Addition of Two New Clinical Consultants to Continue the Advancement of Our Lead Anti-G-CSF Antibody Candidate Towards a First-in-Human Clinical Trial

ME Therapeutics Holdings Inc. Announces the Addition of Two New Clinical Consultants to Continue the Advancement of Our Lead Anti-G-CSF Antibody Candidate Towards a First-in-Human Clinical Trial
Newsfile 7 months ago
ME Therapeutics to Present at Investor Clubhouse at the Canadian Open and Attend the 2024 BIO International Convention for Partnering Opportunities

ME Therapeutics to Present at Investor Clubhouse at the Canadian Open and Attend the 2024 BIO International Convention for Partnering Opportunities
Newsfile 8 months ago
ME Therapeutics Holdings Inc. Announces Ringing of CSE Opening Bell on April 17, 2024

ME Therapeutics Holdings Inc. Announces Ringing of CSE Opening Bell on April 17, 2024
Newsfile 9 months ago
ME Therapeutics Holdings Inc. Announces Upcoming Participation in the 2024 Bloom Burton & Co Health Care Conference and Interview On CSE TV

ME Therapeutics Holdings Inc. Announces Upcoming Participation in the 2024 Bloom Burton & Co Health Care Conference and Interview On CSE TV
Newsfile 10 months ago
ME Therapeutics Announces Closing of Non-Brokered Private Placement

ME Therapeutics Announces Closing of Non-Brokered Private Placement
Newsfile 10 months ago
ME Therapeutics Announces Non-Brokered Private Placement and Provides Corporate Update

ME Therapeutics Announces Non-Brokered Private Placement and Provides Corporate Update
Newsfile 10 months ago
View More

Related Tickers

VRTX.VI Vertex Pharmaceuticals Incorporated
447.90
+5.74%
 
DRUG.CN Bright Minds Biosciences Inc.
47.59
+6.68%
 
XSNX NovAccess Global Inc.
0.0003
0.00%
 
SBM.V Sirona Biochem Corp.
0.0500
0.00%
 
APS.TO Aptose Biosciences Inc.
0.2550
+2.00%
 
MDNA.TO Medicenna Therapeutics Corp.
1.3200
0.00%
 
DTC.CN Defence Therapeutics Inc.
1.0200
-9.73%
 
PXMD PaxMedica, Inc.
0.0310
0.00%
 
MDMA.CN Pharmala Biotech Holdings Inc.
0.2300
+2.22%
 
ONC.TO Oncolytics Biotech Inc.
1.0700
+0.94%